GLP-1 agonists are designed to help people lose weight by aping the action of GLP-1, which is released by the stomach after eating
I have experience managing anxiety, depression, bipolar, schizophrenia, ADHD, insomnia, and other mental disorders in adolescents and adults
They serve as an adjunct tool to support continued appetite control and metabolic health in the long term
Jasmin McVeigh Founder of Bodology Jasmin McVeigh founded Bodology after a personal health breakthrough revealed the central role of metabolic health in conditions like PCOS, Hashimoto's, and PMDD
It is important to know that this is only for the starter doses
Its approval specifically for chronic weight management distinguishes it from many other GLP-1 based medications primarily indicated for diabetes, thereby carving a niche segment focused on the growing global obesity epidemic